We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+2.08%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$770M
AUM Growth
-$1.67M
Cap. Flow
-$10.2M
Cap. Flow %
-1.32%
Top 10 Hldgs %
20.83%
Holding
246
New
3
Increased
56
Reduced
119
Closed
5

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$2.14M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.42M
3
ATR icon
AptarGroup
ATR
+$1.2M
4
GILD icon
Gilead Sciences
GILD
+$1.12M
5
MIDD icon
Middleby
MIDD
+$1.06M

Sector Composition

Rank Sector Weight
1 Healthcare 17.46%
2 Industrials 14.26%
3 Miscellaneous 12.93%
4 Technology 12.61%
5 Consumer Staples 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWK icon
151
Stanley Black & Decker
SWK
$13.4B
$940K 0.12%
8,198
+75
+0.9% +$8.94K
BSX icon
152
Boston Scientific
BSX
$63.6B
$900K 0.12%
41,625
+7,325
+21% +$160K
ESRX
153
DELISTED
Express Scripts Holding Company
ESRX
$894K 0.12%
12,999
-505
-4% -$36.2K
ALK icon
154
Alaska Air
ALK
$4.45B
$881K 0.11%
9,925
STWD icon
155
Starwood Property Trust
STWD
$5.63B
$795K 0.1%
36,196
-868
-2% -$19.1K
COP icon
156
ConocoPhillips
COP
$170B
$791K 0.1%
15,775
-2,527
-14% -$117K
IWO icon
157
iShares Russell 2000 Growth ETF
IWO
$14.1B
$785K 0.1%
5,100
SDY icon
158
State Street SPDR S&P Dividend ETF
SDY
$21.4B
$784K 0.1%
9,160
+20
+0.2% +$1.68K
LLY icon
159
Eli Lilly
LLY
$1.01T
$777K 0.1%
10,565
+165
+2% +$12.3K
STX icon
160
Seagate
STX
$176B
$763K 0.1%
20,000
DNB
161
DELISTED
Dun & Bradstreet
DNB
$757K 0.1%
6,238
+2,020
+48% +$249K
SYNT
162
DELISTED
Syntel Inc
SYNT
$735K 0.1%
37,131
-960
-3% -$20.7K
FCX icon
163
Freeport-McMoran
FCX
$99.6B
$723K 0.09%
54,782
-1,200
-2% -$15.4K
IJH icon
164
iShares Core S&P Mid-Cap ETF
IJH
$122B
$719K 0.09%
21,740
UNFI icon
165
United Natural Foods
UNFI
$2.7B
$711K 0.09%
14,898
LNC icon
166
Lincoln National
LNC
$8.32B
$681K 0.09%
10,276
VIG icon
167
Vanguard Dividend Appreciation ETF
VIG
$111B
$676K 0.09%
7,934
-1,500
-16% -$126K
BUD icon
168
AB InBev
BUD
$156B
$674K 0.09%
6,389
ICUI icon
169
ICU Medical
ICUI
$3.9B
$663K 0.09%
4,500
MDT icon
170
Medtronic
MDT
$120B
$663K 0.09%
9,303
-23
-0.2% -$1.81K
ES icon
171
Eversource Energy
ES
$25.3B
$658K 0.09%
11,905
BNY
172
Bank of New York Mellon
BNY
$105B
$656K 0.09%
13,850
AVNT icon
173
Avient
AVNT
$3.76B
$653K 0.08%
20,394
TRV icon
174
Travelers Companies
TRV
$78.8B
$647K 0.08%
5,283
IWR icon
175
iShares Russell Mid-Cap ETF
IWR
$55.4B
$621K 0.08%
13,892
+368
+3% +$16.1K

Similar funds

Boston Family Office's Q4 2016 Portfolio in Review

As of Q4 2016, Boston Family Office held 246 positions worth $770M, down 0.22% from $772M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 3.3%. Boston Family Office opened 3 new positions and exited 5, leaving the 246-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.

  • Boston Family Office's largest Q4 2016 buy was Juniper Networks: 11,000 shares worth $311K.
  • Boston Family Office added most to CVS Health in Q4 2016, an estimated $2.63M increase.
  • Boston Family Office's biggest Q4 2016 reduction was Stericycle Inc, cutting an estimated $2.14M.
  • Boston Family Office fully exited CF Industries in Q4 2016, selling an estimated $323K.
  • Boston Family Office's ten largest holdings make up 21% of its $770M portfolio in Q4 2016.
  • Boston Family Office opened 3 new positions and closed 5 in Q4 2016.
  • Boston Family Office's portfolio value fell 0.22% quarter-over-quarter to $770M.

Based on Boston Family Office's 13F filing for Q4 2016, filed 6 Feb 2017.